Numis Securities Ltd reaffirmed their buy rating on shares of Georgia Healthcare Group PLC (LON:GHG) in a research note issued to investors on Monday morning. Numis Securities Ltd currently has a GBX 355 ($4.39) price objective on the stock.
Several other research firms have also recently issued reports on GHG. Investec started coverage on Georgia Healthcare Group PLC in a research report on Wednesday, October 5th. They issued a buy rating and a GBX 361 ($4.47) price objective on the stock. Jefferies Group upped their price objective on Georgia Healthcare Group PLC from GBX 280 ($3.47) to GBX 395 ($4.89) and gave the company a buy rating in a research report on Tuesday, July 26th.
Shares of Georgia Healthcare Group PLC (LON:GHG) opened at 308.50 on Monday. The firm has a 50-day moving average price of GBX 298.38 and a 200-day moving average price of GBX 264.03. Georgia Healthcare Group PLC has a 52-week low of GBX 145.00 and a 52-week high of GBX 350.00. The stock’s market capitalization is GBX 395.44 million.
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a United Kingdom-based holding company. The Company provides healthcare services in Georgian healthcare services market. The Company operates in two segments based on products and services: Healthcare services and Medical insurance. The Company’s Healthcare services are the inpatient and outpatient medical services delivered by the referral hospitals, community hospitals and ambulatory clinics owned by the Company throughout the Georgian territory.
Receive News & Ratings for Georgia Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Georgia Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.